We are live on ! Find out more
Franklin Resources

Franklin Resources Portfolio holdings

AUM $464B Turnover 11.72%
1-Year Est. Return 32.11%
 

Franklin Resources is the parent of the Franklin Templeton fund brands, founded in 1947 by Rupert H. Johnson Sr., a Wall Street retail broker who named it after Benjamin Franklin. Rupert Sr.'s son Charles B. Johnson became president and chief executive in 1957, and the company went public in 1971. In 1992 Franklin bought Templeton, Galbraith & Hansberger, which was then owned by mutual fund pioneer Sir John Templeton, and in 2020 it bought Legg Mason. Its fund brands include Franklin for bond funds, Templeton for international funds and Mutual Series for value funds. Its funds include Templeton Growth, opened in 1954, Mutual Shares, opened in 1949, and Mutual Discovery, opened in 1992. It launched its first ETFs in 2013 and a bitcoin and ether ETF in 2025, and in August 2026 Franklin Resources renamed itself Franklin Templeton, Inc. to match its brand.

This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+32.11%
3 Year Est. Return
+131.35%
5 Year Est. Return
+150.39%
10 Year Est. Return
+470.98%
AUM
$220B
AUM Growth
+$1.22B
Cap. Flow
-$6.43B
Cap. Flow %
-2.91%
Top 10 Hldgs %
13.13%
Holding
1,656
New
91
Increased
529
Reduced
663
Closed
88
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
1.3 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.2 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.1 years

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$537M
2
ETR icon
Entergy
ETR
+$492M
3
WFC icon
Wells Fargo
WFC
+$426M
4
CI icon
Cigna
CI
+$374M
5
PEG icon
Public Service Enterprise Group
PEG
+$365M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 12.61%
3 Technology 11.04%
4 Industrials 10.33%
5 Energy 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.6T
$4.19B 1.9%
90,236,005
-2,261,852
-2% -$106M
2013 Q2
6 quarters
MRK icon
2
Merck
MRK
$330B
$3.21B 1.46%
56,558,254
-9,203,491
-14% -$537M
2013 Q2
6 quarters
MDT icon
3
Medtronic
MDT
$128B
$3.21B 1.46%
44,441,551
-751,453
-2% -$52.2M
2013 Q2
6 quarters
TEVA icon
4
Teva Pharmaceutical Industries
TEVA
$45.8B
$3.15B 1.43%
54,827,502
-227,254
-0.4% -$12.7M
2013 Q2
6 quarters
PFE icon
5
Pfizer
PFE
$156B
$3.04B 1.38%
97,560,645
-710,122
-0.7% -$21.5M
2013 Q2
6 quarters
AAPL icon
6
Apple
AAPL
$4.98T
$2.69B 1.22%
97,320,312
-3,573,604
-4% -$97.2M
2013 Q2
6 quarters
TGT icon
7
Target
TGT
$75.1B
$2.5B 1.14%
32,992,866
-2,101,354
-6% -$142M
2013 Q2
6 quarters
CVX icon
8
Chevron
CVX
$407B
$2.43B 1.1%
21,635,543
+187,623
+0.9% +$21.3M
2013 Q2
6 quarters
JPM icon
9
JPMorgan Chase
JPM
$825B
$2.39B 1.08%
38,216,177
-4,505,292
-11% -$271M
2013 Q2
6 quarters
RDS.A
10
DELISTED
Royal Dutch Shell Class A
RDS.A
$2.13B 0.97%
31,805,113
+1,394,337
+5% +$96.5M
2013 Q2
6 quarters
CSCO icon
11
Cisco
CSCO
$357B
$2.08B 0.94%
74,800,288
-11,406,419
-13% -$294M
2013 Q2
6 quarters
PEP icon
12
PepsiCo
PEP
$192B
$2.06B 0.93%
21,745,396
-540,614
-2% -$51.8M
2013 Q2
6 quarters
GM icon
13
General Motors Company Common Stock
GM
$66.4B
$2.05B 0.93%
58,709,680
+5,950,796
+11% +$190M
2013 Q2
6 quarters
GE icon
14
GE Aerospace
GE
$321B
$2.04B 0.92%
10,074,216
+1,149,696
+13% +$236M
2013 Q2
6 quarters
C icon
15
Citigroup
C
$183B
$2.03B 0.92%
37,572,877
+318,803
+0.9% +$16.9M
2013 Q2
6 quarters
LLY icon
16
Eli Lilly
LLY
$1.2T
$1.78B 0.81%
25,862,665
+297,889
+1% +$20.1M
2013 Q2
6 quarters
PCG icon
17
PG&E
PCG
$30.3B
$1.78B 0.81%
33,478,710
-843,063
-2% -$41.8M
2013 Q2
6 quarters
AMGN icon
18
Amgen
AMGN
$236B
$1.72B 0.78%
10,785,296
-393,811
-4% -$61.4M
2013 Q2
6 quarters
BP icon
19
BP
BP
$110B
$1.71B 0.77%
44,759,766
+3,155,773
+8% +$128M
2013 Q2
6 quarters
DUK icon
20
Duke Energy
DUK
$101B
$1.68B 0.76%
20,127,706
-2,093,657
-9% -$169M
2013 Q2
6 quarters
CVS icon
21
CVS Health
CVS
$103B
$1.65B 0.75%
17,151,418
-1,156,723
-6% -$102M
2013 Q2
6 quarters
AIG icon
22
AIG
AIG
$41.3B
$1.65B 0.75%
29,431,760
-305,048
-1% -$16.4M
2013 Q2
6 quarters
EXC icon
23
Exelon
EXC
$47.3B
$1.58B 0.72%
42,529,125
-4,282,418
-9% -$154M
2013 Q2
6 quarters
SO icon
24
Southern Company
SO
$108B
$1.52B 0.69%
30,927,766
-6,492,761
-17% -$307M
2013 Q2
6 quarters
JNJ icon
25
Johnson & Johnson
JNJ
$651B
$1.51B 0.69%
14,460,707
-2,794,350
-16% -$294M
2013 Q2
6 quarters

Similar funds

Franklin Resources's Q4 2014 Portfolio in Review

As of Q4 2014, Franklin Resources held 1,656 positions worth $220B, up 0.56% from $219B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Franklin Resources's Q4 2014 filing shows 91 new, 529 increased, 663 reduced and 88 closed positions. Its largest new stake was Tribune Media: 3,174,130 shares worth $190M. The largest sale was Merck, an estimated $537M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Franklin Resources's largest Q4 2014 buy was Tribune Media: 3,174,130 shares worth $190M.
  • Franklin Resources added most to Anadarko Petroleum in Q4 2014, an estimated $529M increase.
  • Franklin Resources's biggest Q4 2014 reduction was Merck, cutting an estimated $537M.
  • Franklin Resources fully exited iShares MSCI Japan ETF in Q4 2014, selling an estimated $301M.
  • Franklin Resources's ten largest holdings make up 13% of its $220B portfolio in Q4 2014.
  • Franklin Resources opened 91 new positions and closed 88 in Q4 2014.
  • Franklin Resources's portfolio value rose 0.56% quarter-over-quarter to $220B.

Based on Franklin Resources's 13F filing for Q4 2014, filed 10 Feb 2015.